down arrow

Makers Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987A01010
  • NSEID:
  • BSEID: 506919
INR
134.00
0.00 (0.00%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 871

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

131.00135.00

52 Week

114.00230.00
Valuation
Technical
Day's Volume

CASH

871 (-46.38%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.39%

Held by 0 DIIs

Promoter

61.27%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a -58.99% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.90
  • The company has been able to generate a Return on Equity (avg) of 2.94% signifying low profitability per unit of shareholders funds
2

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 79 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.19

stock-summary
Return on Equity

8.81%

stock-summary
Price to Book

1.20

Revenue and Profits (1 Year):
Net Sales:
28 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-11.81%
0%
-11.81%
1 Year
6.18%
0%
6.18%
2 Years
22.59%
0%
22.59%
3 Years
-24.72%
0%
-24.72%
4 Years
-50.74%
0%
-50.74%
5 Years
197.78%
0%
197.78%

Latest dividend: 1 per share ex-dividend date: Aug-01-2019

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.17%
EBIT Growth (5y)
-58.99%
EBIT to Interest (avg)
1.90
Debt to EBITDA (avg)
4.96
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.29
Tax Ratio
23.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.39%
ROCE (avg)
4.92%
ROE (avg)
2.94%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
27
Price to Book Value
1.20
EV to EBIT
81.18
EV to EBITDA
14.89
EV to Capital Employed
1.17
EV to Sales
0.80
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
0.23%
ROE (Latest)
8.81%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Kaygee Investments Private Limited (17.38%)

Highest Public shareholder

Tanvi Jignesh Mehta (2.12%)

Individual Investors Holdings

30.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -6.36% vs -0.07% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -103.40% vs 1,000.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.69",
          "val2": "29.57",
          "chgp": "-6.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.31",
          "val2": "2.18",
          "chgp": "-39.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.19",
          "val2": "0.43",
          "chgp": "-55.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.12",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "8.82",
          "chgp": "-103.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.73%",
          "val2": "7.37%",
          "chgp": "-2.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 18.15% vs -3.62% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 327.62% vs -52.21% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.16",
          "val2": "50.07",
          "chgp": "18.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.00",
          "val2": "-0.01",
          "chgp": "40,100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.92",
          "val2": "0.90",
          "chgp": "2.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.77",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.83",
          "val2": "-3.44",
          "chgp": "327.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.76%",
          "val2": "-0.02%",
          "chgp": "6.78%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.41% vs 6.61% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 251.20% vs -11.41% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "86.85",
          "val2": "76.58",
          "chgp": "13.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.31",
          "val2": "0.20",
          "chgp": "2,555.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.11",
          "val2": "1.43",
          "chgp": "-22.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.77",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.53",
          "val2": "-4.98",
          "chgp": "251.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.11%",
          "val2": "0.26%",
          "chgp": "5.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 3.07% vs -20.02% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -31.79% vs -195.38% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "104.39",
          "val2": "101.28",
          "chgp": "3.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.05",
          "val2": "3.25",
          "chgp": "-67.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.95",
          "val2": "2.12",
          "chgp": "-8.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.26",
          "val2": "-4.75",
          "chgp": "-31.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.01%",
          "val2": "3.21%",
          "chgp": "-2.20%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
27.69
29.57
-6.36%
Operating Profit (PBDIT) excl Other Income
1.31
2.18
-39.91%
Interest
0.19
0.43
-55.81%
Exceptional Items
0.00
0.12
-100.00%
Consolidate Net Profit
-0.30
8.82
-103.40%
Operating Profit Margin (Excl OI)
4.73%
7.37%
-2.64%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -6.36% vs -0.07% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -103.40% vs 1,000.00% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
59.16
50.07
18.15%
Operating Profit (PBDIT) excl Other Income
4.00
-0.01
40,100.00%
Interest
0.92
0.90
2.22%
Exceptional Items
-0.77
0.00
Consolidate Net Profit
7.83
-3.44
327.62%
Operating Profit Margin (Excl OI)
6.76%
-0.02%
6.78%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 18.15% vs -3.62% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 327.62% vs -52.21% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
86.85
76.58
13.41%
Operating Profit (PBDIT) excl Other Income
5.31
0.20
2,555.00%
Interest
1.11
1.43
-22.38%
Exceptional Items
-0.77
0.00
Consolidate Net Profit
7.53
-4.98
251.20%
Operating Profit Margin (Excl OI)
6.11%
0.26%
5.85%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 13.41% vs 6.61% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 251.20% vs -11.41% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
104.39
101.28
3.07%
Operating Profit (PBDIT) excl Other Income
1.05
3.25
-67.69%
Interest
1.95
2.12
-8.02%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-6.26
-4.75
-31.79%
Operating Profit Margin (Excl OI)
1.01%
3.21%
-2.20%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 3.07% vs -20.02% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -31.79% vs -195.38% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Makers Laboratories Ltd stock-summary
stock-summary
Makers Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993.
Company Coordinates stock-summary
Company Details
54 D Kandivli Industrial Estat, Charkop Kandivli (West) Mumbai Maharashtra : 400067
stock-summary
Tel: 91-22-2868 8544
stock-summary
http://www.makerslabs.com
stock-summary
investors@makerslabs.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."